Access the science, technology and contacts that you need to accelerate your biologics and novel products towards commercial success.

REPORT: The Future of Healthcare Post COVID-19

Share this article

COVID-19 has caused an unprecedented disruption to “business as usual” across the globe. From accelerated digitization of the workplace with millions suddenly working from home, to manufacturers pivoting and actually changing their products to help the world cope with new and sudden needs, never before seen or experienced phenomena are happening in businesses around the globe.

Here at Informa Connect Life Sciences, we wanted to discover how COVID-19 is impacting the Life Sciences sector. How are people in the life sciences innovating? Where are they doing it? How successful are their efforts? We surveyed our Life Sciences customers to ask them how their organizations are responding to the crisis. This final report based on the data offers unique insights - read or download it here or by clicking on the image below. 

REPORT: The Future of Healthcare Post COVID-19

Our initial research told us that the most important changes happening right now in organizations fell into these categories: how Life Science organizations manage crises, both before and after COVID-19; the shift to online and working from home or other changes in the workplace; how Life Science companies are trying to be relevant to their customers; and lastly, how they have applied innovations with new business initiatives or products and creating efficiencies.

An April 30 Savanta survey of US consumers gives the mind-blowing figure: “just 24% of respondents plan to go about life the same as before once we emerge from lockdown”, so business innovation is crucial right now. McKinsey recently stated that “It’s possible that entirely new businesses and business models will emerge from the crisis” and that has indeed been proven in our survey. Organizations have been poised to digitally transform their workforces for some time; right now is a turning point, with “trials by fire” bringing in both interesting and unforeseen data.

Our survey results show that COVID-19 has indeed been a disruptor, with 57% of respondents reporting negative financial impact to their businesses, but in many cases companies have been able to turn this disruption into a positive force, by innovating and accelerating the creation of new products as well as cultivating deeper relationships with their customers.

The list of new products and services that survey respondees shared with us were astounding in their diversity. One organization, a telehealth provider, introduced mental health and wellness services, a second explained that they were in the process of "certifying the first 3D printing mask in the world", a third "designed and developed Study Protocols for the COVID-19 response in Africa" and a fourth was developing peptides related to a COVID-19 treatment.

Read or download the full report here.

Share this article

Upcoming event

BioProcess International Europe

27 - 29 Apr 2021, Mark Your Calendar to Join Us Next Year!
Europe’s Leading BioProcessing Event for Accelerating Biologics, mAbs, Vaccines and Novel Products to Commercial Success
Go to site